Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 750 | 1,094 | -14 | 537 | 819 |
| Operating Income | -750 | -1,094 | 14 | -537 | -819 |
| Interest Expense | 67 | 56 | 44 | 55 | 52 |
| Other Income | -1 | 285 | -173 | -42 | -92 |
| Pre-tax Income | -818 | -866 | -203 | -634 | -963 |
| Net Income Continuous | -818 | -866 | -203 | -634 | -963 |
| Minority Interests | -33 | -51 | -80 | -12 | -51 |
| Net Income | $-785 | $-815 | $-124 | $-622 | $-912 |
| EPS Basic Total Ops | -0.01 | N/A | 0.00 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | N/A | 0.00 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | 0.00 | -0.01 | -0.01 |
| EBITDA(a) | $-750 | $-1,079 | $187 | $-495 | $-727 |